semaglutide and glaucoma semaglutide showed no significant associations with the risk of diabetic retinopathy - SemaglutideNAION semaglutide Semaglutide and Glaucoma: Untangling the Emerging Research

SemaglutideNAION mechanism The widespread use of semaglutide, a popular medication for type 2 diabetes and weight management, has prompted extensive research into its potential effects, including its relationship with glaucoma and other eye conditionsGLP-1 Receptor Agonists and Intraocular Pressure Change. While some studies suggest a potential link to certain ocular risks, others indicate no significant associations and even explore potential protective benefits.A Study Investigating Oral Semaglutide in People with ... This article delves into the current understanding of semaglutide and glaucoma, examining the evidence for both concerns and potential benefits, and aims to provide a comprehensive overview.Semaglutide May Be Associated With Increased Risk ...

Understanding the Evolving Landscape of Semaglutide and Eye Health

Semaglutide belongs to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs). These medications work by mimicking the action of the GLP-1 hormone, which helps regulate blood sugar and appetite. As the prescription of GLP-1 RAs like Ozempic and Wegovy has surged, so has the scientific inquiry into their broader health implications.

One of the primary areas of focus has been the risk of Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), often referred to as an "eye stroke." Several large epidemiological studies have investigated the association between semaglutide use and NAION. One notable matched cohort study involving 16,827 patients indicated a higher risk of NAION in patients prescribed semaglutide compared to those on other medicationsSemaglutide links to eye disorders in spotlight. Similarly, other research suggests that semaglutide or tirzepatide was associated with a more modest risk of developing NAION than previously thought.GLP-1 Receptor Agonists and vision risk The European Medicines Agency's safety committee has flagged that these weekly injections may, in very rare cases, cause a serious eye condition that can lead to vision loss. The mechanism of semaglutide NAION is still under investigation, but theories suggest that semaglutide potentially disrupts the regional homeostasis of the retina in individuals who experience a rapid response to the medication.

However, the narrative is not entirely cautionaryOzempic and other weight-loss drugs linked to rare but .... Some comprehensive systematic reviews have concluded that semaglutide showed no significant associations with the risk of diabetic retinopathy or general ocular issues. Another systematic review on ocular adverse events indicated that semaglutide was not associated with an increased risk of eye disorders佛历2567年8月28日—Patients treated with a GLP-1RA agonist had a 41-50% lower relative risk of developing primary open-angleglaucoma(POAG) after 1-3 years of .... This suggests that for many individuals, the medication might not pose a heightened threat to their vision.

Exploring Potential Neuroprotective Effects and Therapeutic Applications

Beyond potential risks, research is also exploring whether semaglutide might offer beneficial effects for certain eye conditions, including glaucoma. Preclinical studies have indicated that GLP-1 receptor agonists, including semaglutide, offer promising potential for neuroprotection due to their anti-inflammatory, anti-oxidative, and anti-apoptotic effects. These findings have led to investigations into their application in neurodegenerative conditions affecting the eyeDoes semaglutide provide neuroprotection in models of ....

Indeed, semaglutide is a medication being studied in this clinical trial to assess its potential to improve the function of the inner retina in patientsGlucagon-Like Peptide 1 Receptor Agonists – Potential ... - PMC. Furthermore, a study is investigating oral semaglutide can be used to treat open-angle glaucoma.佛历2568年10月9日—According to this systematic review,semaglutide showed no significant associations with the risk of diabetic retinopathyor general ocular ... These ongoing trials highlight the active exploration of semaglutide's role in glaucoma treatment.Popular Type 2 Diabetes Drug Could Possibly Lower ...

Compellingly, some research suggests that GLP-1 RAs may offer protection against glaucoma development. A study found that patients treated with a GLP-1 RA had a 41-50% lower relative risk of developing primary open-angle glaucoma (POAG) after 1-3 years of use. Danish research has also shown that the risk of developing glaucoma is lower in diabetes patients who are prescribed semaglutide.Can Ozempic Affect Your Eyes or Vision? - Texas Retina ... In a fascinating preclinical study, systemic semaglutide provides a mild vasoprotective and antineuroinflammatory effect in a rat model of ocular hypertensive glaucoma. These findings suggest that the GLP-1 RA class may have intrinsic properties beneficial for eye health, particularly for conditions like glaucoma佛历2568年6月18日—All weight-loss drugs have the potential to change the shape of the eye lens, which can cause transient blurring of vision..

Understanding Ocular Adverse Events and Patient Considerations

While the overall outlook for semaglutide and glaucoma is becoming clearer, it's crucial for patients and healthcare providers to be aware of reported ocular adverse events. Some clinical studies have noted that a small number of people taking semaglutide may experience vision changes or a worsening of their diabetic retinopathy. It's also reported that semaglutide was associated with ocular adverse events, such as the worsening of diabetic retinopathy.

In rare instances, semaglutide has been linked to specific eye conditions such as papilledema and macular edema. However, it's important to note that these associations are often found to be less pronounced when compared to other diabetes medications like metformin.

For individuals considering or currently using semaglutide, it is paramount to maintain open communication with their healthcare provider.佛历2568年9月5日—Researchers have observed that patients prescribedsemaglutide, the active ingredient in both drugs, had an increased risk of nonarteritic ... Patients experiencing sudden vision loss or rapidly worsening eyesight during treatment with semaglutide should contact their doctor immediately. While glaucoma in itself is not a contraindication for medications like Wegovy (which contains semaglutide), and current evidence doesn't establish a definitive link between semaglutide and the worsening of glaucoma, ongoing vigilance is essential.

The research surrounding semaglutide and glaucoma is dynamic and continually evolvingSemaglutide links to eye disorders in spotlight. While some concerns regarding NAION have been raised, ongoing trials exploring potential therapeutic benefits for glaucoma and other eye conditions are promising. As more data emerges, a clearer picture of the intricate relationship between this widely used medication and ocular health will undoubtedly continue to develop作者：GR Natividade·2025·被引用次数：17—Despite its favorable safety profile, the use ofsemaglutide was associated with ocular adverse eventsas worsening of diabetic retinopathy and ....